Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition by J. H. Börner, S. Neuberger, E. Juengel, S. Ziewers, R. Dotzauer, P. Sparwasser, T. Höfner, I. Tsaur, A. Haferkamp, R. Mager

Get full text